| RS1568404443 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1568404922 |
LTBP4
|
Health Risk |
Likely pathogenic |
Cutis laxa, Cutis laxa |
| RS1568406407 |
LTBP4
|
Health Risk |
Pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS1568408269 |
PNPLA6
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS1568408280 |
MAST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, Inborn genetic diseases |
| RS1568409494 |
MAST1
|
Health Risk |
Likely pathogenic |
Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations |
| RS1568409502 |
MAST1
|
Health Risk |
Pathogenic |
Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations |
| RS1568409626 |
TUBB4A
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS1568409639 |
TUBB4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypomyelinating leukodystrophy 6, Hypomyelinating leukodystrophy 6 |
| RS1568413207 |
MAST1
|
Health Risk |
Pathogenic |
Mega-corpus-callosum syndrome with cerebellar hypoplasia and cortical malformations, MAST1-related disorder |
| RS1568413644 |
OPA3
|
Health Risk |
Pathogenic/Likely pathogenic |
3-Methylglutaconic aciduria type 3, Optic atrophy 3 |
| RS1568415448 |
PNPLA6
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS1568418845 |
FKRP
|
Health Risk |
Pathogenic |
— |
| RS1568419433 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1568419654 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1568419664 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1568419675 |
SMARCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1568419701 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568419736 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1568419860 |
FKRP
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS1568420774 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1568420836 |
KLF1
|
Health Risk |
Pathogenic |
BLOOD GROUP--LUTHERAN INHIBITOR, BLOOD GROUP--LUTHERAN INHIBITOR |
| RS1568420988 |
KLF1
|
Health Risk |
Pathogenic |
— |
| RS1568421853 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1568422286 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568422504 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568423251 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Rhabdoid tumor predisposition syndrome 2 |
| RS1568423542 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568423738 |
SLC5A5
|
Health Risk |
Pathogenic/Likely pathogenic |
Thyroid dyshormonogenesis 1, Thyroid dyshormonogenesis 1 |
| RS1568423807 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568423844 |
PNPLA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS1568424857 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS1568425218 |
RPL18
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 18, Diamond-Blackfan anemia 18 |
| RS1568425945 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS1568426700 |
INSR
|
Health Risk |
Likely pathogenic |
Insulin resistance, Insulin resistance |
| RS1568427296 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568427678 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1568428779 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1568429137 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1568429257 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1568429421 |
GCDH
|
Health Risk |
Likely pathogenic |
Glutaric aciduria, type 1 |
| RS1568430264 |
PRR12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1568430280 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1568431102 |
CD70
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CD70 deficiency, Severe combined immunodeficiency due to CD70 deficiency |
| RS1568431262 |
CD70
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CD70 deficiency, Severe combined immunodeficiency due to CD70 deficiency |
| RS1568440440 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebellar ataxia, Episodic ataxia type 2 |
| RS1568440962 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Central core myopathy |
| RS1568441076 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568443280 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568443969 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568445341 |
PEPD
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1568445415 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568445893 |
ARSG
|
Health Risk |
Pathogenic |
Usher syndrome, type 4 |
| RS1568446845 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568447557 |
CACNA1A
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568447650 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic ataxia, Developmental and epileptic encephalopathy |
| RS1568450514 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1568451320 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1568452917 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1568453378 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1568454093 |
NPHS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS1568454672 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1568455217 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1568456200 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 16 |
| RS1568456335 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS1568457080 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568462513 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1568463402 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS1568466685 |
ETFB
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS1568469505 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1568469857 |
CACNA1C
|
Health Risk |
Pathogenic |
Long QT syndrome 8, Long QT syndrome 8 |
| RS1568469902 |
BLOC1S3
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 8, Hermansky-Pudlak syndrome 8 |
| RS1568470104 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568471940 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1568471977 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
CACNA1A-related disorder, Seizure |
| RS1568472223 |
ERF
|
Health Risk |
Likely pathogenic |
— |
| RS1568472771 |
ERF
|
Health Risk |
Pathogenic |
TWIST1-related craniosynostosis, TWIST1-related craniosynostosis |
| RS1568473171 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Inborn genetic diseases |
| RS1568473233 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568473283 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia type 6, Spinocerebellar ataxia type 6 |
| RS1568475667 |
ERF
|
Health Risk |
Pathogenic |
TWIST1-related craniosynostosis, TWIST1-related craniosynostosis |
| RS1568476007 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1568476203 |
RYR1
|
Health Risk |
Pathogenic |
Congenital multicore myopathy with external ophthalmoplegia, Congenital multicore myopathy with external ophthalmoplegia |
| RS1568480054 |
LIM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract, Cataract 19 multiple types |
| RS1568480914 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1568481204 |
COLGALT1
|
Health Risk |
Pathogenic |
Brain small vessel disease 3, Brain small vessel disease 3 |
| RS1568481244 |
COLGALT1
|
Health Risk |
Pathogenic |
Brain small vessel disease 3, Brain small vessel disease 3 |
| RS1568481364 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1568482840 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1568483365 |
AURKC
|
Health Risk |
Likely pathogenic |
— |
| RS1568483598 |
NLRP5
|
Health Risk |
Pathogenic |
— |
| RS1568484575 |
B9D2
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 10 |
| RS1568484835 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1568485068 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568485109 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS1568487734 |
CIC
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 45 |
| RS1568490874 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1568493323 |
CACNA1A
|
Health Risk |
Pathogenic |
Episodic ataxia type 2, Episodic ataxia type 2 |
| RS1568494824 |
CACNA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1568495944 |
CACNA1A
|
Health Risk |
Pathogenic |
— |